- Home
- WTF vs AUTL Comparison
WTF vs AUTL Comparison
Compare WTF & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTF
- AUTL
- Stock Information
- Founded
- WTF 1989
- AUTL 2014
- Country
- WTF Hong Kong
- AUTL United Kingdom
- Employees
- WTF N/A
- AUTL N/A
- Industry
- WTF
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WTF
- AUTL Health Care
- Exchange
- WTF NYSE
- AUTL Nasdaq
- Market Cap
- WTF 315.5M
- AUTL 359.3M
- IPO Year
- WTF 2025
- AUTL 2018
- Fundamental
- Price
- WTF $6.60
- AUTL $1.75
- Analyst Decision
- WTF
- AUTL Strong Buy
- Analyst Count
- WTF 0
- AUTL 5
- Target Price
- WTF N/A
- AUTL $9.32
- AVG Volume (30 Days)
- WTF 121.0K
- AUTL 2.4M
- Earning Date
- WTF 01-01-0001
- AUTL 05-08-2025
- Dividend Yield
- WTF N/A
- AUTL N/A
- EPS Growth
- WTF N/A
- AUTL N/A
- EPS
- WTF 0.04
- AUTL N/A
- Revenue
- WTF $10,508,879.00
- AUTL $9,011,000.00
- Revenue This Year
- WTF N/A
- AUTL $329.53
- Revenue Next Year
- WTF N/A
- AUTL $191.73
- P/E Ratio
- WTF $177.99
- AUTL N/A
- Revenue Growth
- WTF 4482.47
- AUTL N/A
- 52 Week Low
- WTF $4.05
- AUTL $1.11
- 52 Week High
- WTF $19.85
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- WTF N/A
- AUTL 66.44
- Support Level
- WTF N/A
- AUTL $1.19
- Resistance Level
- WTF N/A
- AUTL $1.79
- Average True Range (ATR)
- WTF 0.00
- AUTL 0.11
- MACD
- WTF 0.00
- AUTL 0.05
- Stochastic Oscillator
- WTF 0.00
- AUTL 93.39
About WTF WATON FINANCIAL LIMITED
Waton Financial Ltd is a holding company that operates its business through subsidiaries in the securities brokerage and distribution services, margin financing services, and other ancillary services business; Software licensing and related support services, including licensing of trading platform applications, upgrades and enhancements, maintenance; and other associated services to securities brokers and financial institutions. The group also provided software licensing and related support services, including licensing trading platform applications, and others.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.